Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

MabThera/Rituxan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.

Imbruvica gains expanded use in Europe

Imbruvica gains expanded use in Europe drug. . The EC has approved the use of Imbruvica in combination with obinutuzumab (Gazyva, Roche) in adult patients with previously untreated chronic lymphocytic leukaemia (CLL) and in combination with rituximab (Rituxan,

Triplet approvals for myeloma boost Celgene in Q2

Triplet approvals for myeloma boost Celgene in Q2 Revlimid could get additional upside if it can claim approval in combination with Roche’s Rituxan (rituximab) for indolent lymphoma, with the results of the MAGNIFY trial due later this year,

New products help lift Roche outlook despite biosimilar onslaught

New products help lift Roche outlook despite biosimilar onslaught This was all achieved despite heavy erosion of sales in Europe thanks to biosimilars - the group's total sales fell 4% in the region, with Herceptin revenues down 45% and ... Rituxan shrinking 36%.

Roche’s Polivy gets FDA okay for lymphoma chemo-immunotherapy

Roche’s Polivy gets FDA okay for lymphoma chemo-immunotherapy The antibody-drug conjugate has been cleared for use alongside the chemotherapy bendamustine and Roche’s blockbuster immunotherapy Rituxan (rituximab) as a regimen for adults with diffuse large B-cell lymphoma ... 1b/2 study in 80 patients with DLBCL

AZ’s Calquence threatens Imbruvica with new leukaemia data

AZ’s Calquence threatens Imbruvica with new leukaemia data The ASCEND study pitted Calquence against Roche’s Rituxan (rituximab) combined with either Gilead’s Zydelig (idelalisib) or bendamustine, and will be used to support regulatory filings later this year along

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics